Večer advocates for vaccine over anti-Covid drug Lagevrio
Ljubljana, 9 December - The newspaper Večer problematises in Thursday's commentary the new anti-Covid drug Lagevrio, also known as molnupiravir. The drug has raised more eyebrows than any any vaccine so far, it says.
The rest of this news item is available to subscribers.
The news item consists of 1.393 characters (without spaces) or 291 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.